Dopac

HCID 547CAS 102-32-9

Basic information

Standard SMILES
O=C(O)Cc1ccc(O)c(O)c1
InChIKey
CFFZDZCDUFSOFZ-UHFFFAOYSA-N
Molecular formula
C8H8O4
Average molar mass
168.15 g/mol
Monoisotopic mass
168.04225874

Overview

(3,4-dihydroxyphenyl)acetic acid is a dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine. It has a role as a human metabolite. It is a member of catechols and a dihydroxyphenylacetic acid. It is functionally related to a phenylacetic acid. It is a conjugate acid of a (3,4-dihydroxyphenyl)acetate.

Names & identifiers

Preferred name
Dopac
IUPAC
2-(3,4-dihydroxyphenyl)acetic acid
English name
3,4-Dihydroxyphenylacetic acid
Molecular formula
C8H8O4
Molecular weight
168.15

Names & synonyms

3,4-Dihydroxyphenylacetic acid102-32-9Dopac2-(3,4-DIHYDROXYPHENYL)ACETIC ACIDHomoprotocatechuic acidDopacetic acidBenzeneacetic acid, 3,4-dihydroxy-Acetic acid, (3,4-dihydroxyphenyl)-BA 2773KEX5N0R4N5NSC-73191DTXSID9074430
Show more names
N,N-DIMETHYL-P-PHENYLENEDIAMINE SULFATE3,4-DihydroxyphenyLba2773dopaceticacid
HMDB013363,4 Dihydroxyphenylacetic AcidRefChem:486240DTXCID3032676203-024-13,4-Dihydroxybenzeneacetic acidDihydroxyphenylacetic acid(3,4-DIHYDROXYPHENYL)ACETIC ACID

Database identifiers

CAS
102-32-9
PubChem CID
547
DTXSID
DTXSID9074430
ChEMBL
CHEMBL1284
ChEBI
CHEBI:41941
UNII
KEX5N0R4N5
EC Number
203-024-1
Nikkaji
J804D

Properties

Computed structural properties

XLogP
0.5
Topological polar surface area
77.8 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
4
Rotatable bonds
2
Heavy atoms
12

Experimental & physicochemical properties

Chemical ClassesOther Classes -> Organic Acids
DrugsPharmaceuticals -> Listed in ZINC15
LogP · 2 items

0.98

0.98

Solubility4 mg/mL
Melting Point168 °C
Vapor Pressure0.00000082 [mmHg]

Physicochemical properties

Melting point
127 · 127-130 °C (lit.)
Boiling point
257.07 °C · 257.07°C (rough estimate)
Density
1.3037 · 1.3037 (rough estimate)
refractive index
1.509 · 1.5090 (estimate)
storage temp.
Inert atmosphere,Room Temperature
solubility
50 mg/mL, · water: soluble50mg/mL, clear, almost colorless

Safety & regulation

GHS classification

GHS Classification · 4 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazards SummaryA skin and strong eye irritant; [Alfa Aesar MSDS]
Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Safety data

F
10-23
PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
AH0590000
hs_code
29182900
risk_code
36/37/38

Chemistry & industry

Pharmacology

Metabolism/Metabolites3,4-dihydroxyphenylacetic acid has known human metabolites that include 3-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, and Protocatehuic acid.
Tissue LocationsBrain
Cellular LocationsCytoplasm
Metabolite PathwaysAlkaptonuria

Uses & manufacturing

UsesA deaminated metabolite of LEVODOPA. [ChemIDplus]
Applications · 4 items

Description3,4-Dihydroxyphenylacetic acid (DOPAC) is a metabolite of the neurotransmitter dopamine. Dopamine can be metabolized into one of three substances. One such substance is DOPAC. Another is 3-methoxytyramine (3-MT). Both of these substances are degraded to form homovanillic acid (HVA). Both degradations involve the enzymes monoamine oxidase (MAO) and catechol-O-methyl transferase (COMT), albeit in reverse order: MAO catalyzes dopamine to DOPAC, and COMT catalyzes DOPAC to HVA; whereas COMT catalyzes dopamine to 3-MT and MAO catalyzes 3-MT to HVA. The third metabolic end-product of dopamine is norepinephrine (noradrenaline).DOPAC can be oxidized by hydrogen peroxide, leading to the formation of toxic metabolites which destroy dopamine storage vesicles in the substantia nigra. This may contribute to the failure of levodopa treatment of Parkinson's disease. A MAO-B inhibitor such as selegiline or rasagiline can prevent this from happening.wikipedia

Uses3,4-Dihydroxyphenylacetic Acid is a metabolite of Dopamine (D533782).

Uses3,4-Dihydroxyphenylacetic acid is an important metabolite when studying the behavior of the dopaminergic system.

General Description3,4-dihydroxyphenylacetic acid (DOPAC) is a normal constituent of rat brain tissue. A mass fragmentographic method for determination of DOPAC in rat brain tissue has been described. It is major metabolite of dopamine (DA). The voltammetric reduction of DOPAC has been studied at a glassy carbon electrode modified with single-wall carbon nanotubes (SWNTs). Semi-automatic fluorometric assay technique for DOPAC has been reported.

Suppliers50 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Shanghai Biolang Biotechnology Co., Ltd.+86-15970428662 +86-13397199602 · [email protected]
Additional notes · 1 item

DefinitionChEBI: (3,4-dihydroxyphenyl)acetic acid is a dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine. It has a role as a human metabolite. It is a dihydroxyphenylacetic acid and a member of catechols. It is functionally related to a phenylacetic acid. It is a conjugate acid of a (3,4-dihydroxyphenyl)acetate.

Related reactions

20 records

Linked notes

Loading…